T1	p 45 88	patients with isolated hypertriglyceridemia
T2	p 223 239	artery disease .
T3	p 356 399	patients with isolated hypertriglyceridemia
T4	p 414 454	study included 39 patients with elevated
T5	p 479 516	peripheral artery sclerosis , treated
T6	p 1281 1303	patients with isolated
T7	p 1376 1398	patients with elevated
T8	i 16 27	simvastatin
T9	i 294 315	simvastatin treatment
T10	i 534 557	either simvastatin ( 40
T11	i 561 581	daily ) or placebo .
T12	i 707 718	Simvastatin
T13	i 729 738	placebo ,
T14	i 864 870	factor
T15	i 930 951	plasminogen activator
T16	i 1194 1210	statin treatment
T17	o 108 136	Elevated triglyceride levels
T18	o 183 213	and accelerated progression of
T19	o 324 339	coagulation and
T20	o 455 496	triglyceride levels and peripheral artery
T21	o 582 650	Plasma lipids , glucose homeostasis markers and hemostasic variables
T22	o 778 814	plasma levels/activity of fibrinogen
T23	o 864 874	factor VII
T24	o 926 963	and plasminogen activator inhibitor-1
T25	o 1051 1088	in von Willebrand factor levels , and
T26	o 1111 1134	prothrombin and partial
T27	o 1249 1264	coagulation and
T28	o 1399 1420	triglyceride levels .